Skip Navigation
ChemIDplus LiteBrowseAdvanced

Substance Name: Reslizumab [USAN:INN]
RN: 241473-69-8
UNII: 35A26E427H


  • Humanized anti-IL-5 monoclonal antibody for treatment in patients with nasal polyps.
  • Humanized anti-IL-5 monoclonal antibody used for treatment in patients with nasal polyps. It is also used in the treatment of ASTHMA.

Molecular Formula

  • Unspecified

Classification Codes

  • Anti-Asthmatic Agents
  • Respiratory System Agents
  • Treatment of Bronchial Asthma as Well as a Pharmacological Tool Toelucidate the Role of IL-5 in Human Eosinophilic Diseases
* denotes mobile formatted website

Links to Resources

Names and Synonyms

Name of Substance

  • Reslizumab [USAN:INN]


  • CEP-38072
  • CEP38072
  • Cinqair
  • DCP 835
  • DCP-835
  • DCP835
  • Reslizumab
  • Sch 55700
  • SCH-55700
  • SCH55700
  • UNII-35A26E427H

Systematic Name

  • Immunoglobulin G4, anti-(human interleukin 5) (human-rat monoclonal SCH 55700 gamma4-chain), disulfide with human-rat monoclonal SCH 55700 light chain, dimer

Registry Numbers

CAS Registry Number

  • 241473-69-8


  • 35A26E427H

Other Registry Number

  • 339087-64-8

System Generated Number

  • 0241473698